This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

PROACT II trial

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Prolyse in Acute Cerebral Thromboembolism II included patients with arteriographically confirmed occlusion of the middle cerebral artery or first order branch.

12,323 patients were screened, 474 underwent arteriography, 180 were enrolled and 121 received local intrarterial prourokinase and low dose intravenous heparin within 6 hours of symptom onset, 59 received low dose intravenous heparin alone.

40% of patients treated with prourokinase were able to live independently at 3 months whilst only 25% acheived this in the heparin-only group.

Intracerebral haemorrhage and neurologic deterioration occurred in 10% of the prourokinase patients compared to 2% of the heparin only group.

Reference:

  • (1) Brott, Bogousslavsky (2000). Treatment of acute ischaemic stroke. NEJM, 343, 710-722

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.